Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
07/2012
07/25/2012CN102600483A CdTe/ZnS/polyether/folic acid core-shell type nanoparticle
07/25/2012CN102078624B Efficient Gd-loaded liposome preparation and preparation method thereof
07/25/2012CN101732723B Polyethylene glycol-poly(lactic-co-glycolic acid)-polylysine nano-delivery system, preparation method and application thereof
07/24/2012US8229198 Method for creating image recordings relating to the blood vessel system of a patient using a variable-position detector of a digital subtraction angiography facility and associated facility
07/24/2012US8226930 Synthetic MeCP2 sequence for protein substitution therapy
07/24/2012US8226929 Contrast agents for myocardial perfusion imaging
07/24/2012CA2410887C Compounds for targeting endothelial cells, compositions containing the same and methods for their use
07/19/2012WO2012097220A2 Novel vesicles and nanostructures from recombinant proteins
07/19/2012WO2012066006A3 Agents and methods for visualising analytes
07/19/2012WO2012058418A3 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy
07/19/2012WO2012051323A3 Cryptophane derivatives and methods of use thereof
07/19/2012WO2012050810A3 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging
07/19/2012WO2012033901A3 Somatostatin receptor-based cancer therapy
07/19/2012US20120184545 Heart-slowing drug containing short-acting beta-blocker as teh active ingredient
07/19/2012US20120184050 Multiplex screening for lysosomal storage disorders (lsds)
07/19/2012US20120183927 Dental Compositions for Improving Brushing Habits
07/19/2012US20120183478 Compositions, Devices, and Methods related to Prostate-Specific Membrane Antigen
07/19/2012US20120183477 Therapeutic Antibody Target Validation and Screening In Vivo
07/19/2012US20120183476 Methods of administering liquid droplet aerosols of nanoparticulate drugs
07/19/2012US20120183475 Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
07/19/2012US20120183474 Methods and System for Detecting Soluble Amyloid-Beta
07/19/2012CA2824143A1 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
07/18/2012EP2476683A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
07/18/2012EP2476424A1 Orally administrable tablet for intestinal lavage
07/18/2012EP2476009A1 13c-mr detection using hyperpolarised 13c-fructose
07/18/2012EP2475399A1 Methods for diagnosis and intervention of hepatic disorders
07/18/2012EP2475363A1 Detection of mycobacteria
07/18/2012EP2203189B1 Contrast agents
07/18/2012EP2200655B1 Contrast agents
07/18/2012CN102597770A Use Of Alpha-methylglucoside (amg) As An Indicator For Glucose Absorption And Excretion
07/18/2012CN102596257A Diagnostic composition comprising plasma cations having superior safety profile
07/18/2012CN102586174A Pluripotent cell derived from cataract mouse model, its preparation method and application
07/18/2012CN102585258A Gelatin embolism microsphere and preparation method and application thereof
07/18/2012CN102585202A Dendritic polyglycerol sulfates and sulfonates and their use for inflammatory diseases
07/18/2012CN102584869A 2-nuclear magnetic resonance imaging contrast agent taking 2, 3-biquinoxaline as connecting body and preparation method thereof
07/18/2012CN102580124A Medical disinfecting ultrasound gel composition and preparation method
07/18/2012CN102580123A Capsule for examining massive gastric retention patients with ultrasonic
07/18/2012CN102580122A Method for preparing medical disinfection couplant
07/18/2012CN102580121A Medical disinfection coupling agent
07/18/2012CN102580120A Targeted magnetic resonance imaging (MRI) contrast agent and preparation method thereof
07/18/2012CN102580119A Reagent for monitoring immune state of rabbit after skin grafting, and preparation method thereof
07/18/2012CN102579336A MRI(magnetic resonance imaging)-visible hyperstable doxorubicin nanomicelle medicine transmission system, preparation method thereof and use thereof
07/18/2012CN102578039A Zebrafish liver replication model for human HCV (hepatitis C virus) genes
07/18/2012CN102172409B Biological assay method and device for detecting toxicity potency of aconite traditional Chinese medicines
07/18/2012CN102107013B Sterile ultrasound coupling agent for invasive ultrasound diagnosis and treatment and preparation method thereof
07/18/2012CN101716354B Ultrasonic coupling agent
07/17/2012US8224424 Tissue site markers for in vivo imaging
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012US8221735 Embolic compositions
07/17/2012CA2559250C X-ray visible drug delivery device
07/17/2012CA2545065C Method of identifying responders to treatment with insulin sensitizers
07/17/2012CA2523672C Compositions for enhancing transport of molecules into cells
07/17/2012CA2322559C Compositions and methods for modulating vascularization
07/12/2012WO2012094620A2 Hydrophobic molecule-induced branched polymer aggregates and their use
07/12/2012WO2012094541A2 Acoustically responsive particles with decreased cavitation threshold
07/12/2012WO2012092692A1 Locating needle used in synchronous detection of ct and mri
07/12/2012WO2012051170A3 Imaging of meningiomas using phingylbenzothiazole, stilbene, or biphenylalkyne derivatives
07/12/2012WO2012031280A3 Identification and enrichment of cell subpopulations
07/12/2012US20120180144 Animal models of neurological disorders
07/12/2012US20120180143 Transgenic animal model of neurodegenerative disorders
07/12/2012US20120180141 Transgenic Animal Models of Disease
07/12/2012US20120177638 Antibodies to vla-1
07/12/2012US20120177581 Bystander immune suppression as a predictor for response to a vaccine
07/12/2012US20120177580 Metal Abstraction Peptide (MAP) Tag and Associated Methods
07/12/2012US20120177579 Metal Abstraction Peptide (MAP) Tag and Associated Methods
07/12/2012US20120177578 Compositions, methods, and systems comprising fluorous-soluble polymers
07/12/2012US20120177577 Genetically Modified Rat Models for Severe Combined Immunodeficiency (SCID)
07/12/2012US20120177576 Optical device and method for non-invasive real-time testing of blood sugar levels
07/12/2012US20120177575 Fas (apo-1,cd95) targeted platforms for intracellular drug delivery
07/12/2012US20120177574 Microvesicles derived from nucleated, mammalian cells and use thereof
07/12/2012US20120177573 Methods for conjugating nucleic acids with small molecules
07/12/2012US20120177568 Novel meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
07/12/2012CA2824063A1 Hydrophobic molecule-induced branched polymer aggregates and their use
07/11/2012EP2474553A2 Compounds for diagnosing apoptosis
07/11/2012EP2474327A1 Microdosing of ultrasound contrast agents
07/11/2012EP2474326A1 Molecular probe for imaging islets of langerhans, and use therefore
07/11/2012EP2473199A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders
07/11/2012EP2473198A2 Systems and methods for producing hyperpolarized materials and mixtures thereof
07/11/2012EP2473192A1 Dispersant stabilization of inorganic non-metallic particles
07/11/2012EP2473095A1 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
07/11/2012EP2231199B1 Fluorescent marker for cell death in the eye
07/11/2012EP2121039B1 Nanoparticle clusters and methods for forming same
07/11/2012EP2016046B1 Contrast agents
07/11/2012CN102573925A Contrast agent for photoacoustic imaging and photoacoustic imaging method utilizing same
07/11/2012CN102573923A Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
07/11/2012CN102573914A Porphyrin nanovesicles
07/11/2012CN102573910A Targeted nano-photomedicines for photodynamic therapy of cancer
07/11/2012CN102573612A Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
07/11/2012CN102558431A Preparation method of tumor developer folate--poly hydroxyethyl acrylate-diethylenetriamine pentaacetic acid
07/11/2012CN102558354A Human-mouse chimeric monoclonal antibody against human platelet membrane glycoprotein Ib alpha and applications of human-mouse chimeric monoclonal antibody
07/11/2012CN102558343A Mutant growth hormone receptor and application thereof
07/11/2012CN102558334A Peptides that selectively home to heart vasculature and related conjugates and methods
07/11/2012CN102557969A Cyclic ketone derivatives and applications thereof as developers and aggregation inhibitors of amyloid protein sediments and neurofibrillary tangles
07/11/2012CN102557149A Method for preparing water-soluble nanometer iron oxide
07/11/2012CN102552947A Cation microvesicle and preparation method thereof
07/11/2012CN102552946A Double-mode imaging and medicine-loading integrated nano medicine carrier and preparation method thereof
07/11/2012CN102552945A Surface modification method of magnetic iron oxide nano-particles
07/11/2012CN102552944A Nasopharyngeal carcinoma targeted magnetic resonance contrast agent and preparation method thereof
07/11/2012CN102552943A Tumor targeting magnetic resonance contrast medium modified by chlorotoxin and preparation method and application thereof
07/11/2012CN102552942A Magnetic mesoporous nano-composite material responding to external temperature or pH value and preparation method and application thereof
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 354